Related Experiment Videos
Pregnancy after cardiac transplantation
1Department of Obstetrics and Gynecology, Sloane Hospital for Women, Columbia-Presbyterian Medical Center, New York, NY 10032.
American Journal of Obstetrics and Gynecology
|July 1, 1993
Summary
A heart transplant recipient with hypertrophic cardiomyopathy successfully delivered vaginally. Her pregnancy was managed with immunosuppressants despite renal issues and hypertension.
Area of Science:
- Cardiology
- Obstetrics
- Pharmacology
Background:
- Familial hypertrophic cardiomyopathy (HCM) is a significant concern, often necessitating advanced cardiac interventions like transplantation.
- Cardiac transplantation is a life-altering procedure, and subsequent pregnancies in recipients present unique medical challenges.
- Managing immunosuppressive therapy during pregnancy requires careful consideration of maternal and fetal well-being.
Observation:
- A patient with a history of cardiac transplantation for familial hypertrophic cardiomyopathy 4 years prior was evaluated during pregnancy.
- The patient's immunosuppressive regimen included cyclosporine, prednisone, and azathioprine.
- During pregnancy, the patient exhibited signs of renal insufficiency and developed pregnancy-induced hypertension.
Findings:
- The patient underwent a successful normal spontaneous vaginal delivery.
- The successful vaginal delivery demonstrates the feasibility of childbirth in select cardiac transplant recipients.
- The management of immunosuppression and comorbid conditions was critical for a positive outcome.
Implications:
- This case highlights the potential for successful pregnancy and delivery in women with a history of cardiac transplantation for HCM.
- It underscores the importance of multidisciplinary care involving cardiology, obstetrics, and nephrology for managing complex pregnancies.
- Further research into optimal immunosuppressive strategies and management of hypertensive disorders in pregnant transplant recipients is warranted.